CMS CRUSH Proposed Rule: What Healthcare Organizations Need to Know

Cover graphic: CMS CRUSH Proposed Rule, what healthcare organizations need to know, with a magnifier over regulatory documents marked Proposed Rule

The headline number in the CMS CRUSH proposed rule is nearly $90 billion in estimated federal savings, and most of the coverage will stop there. The provisions that should actually hold a practice leader's attention are quieter, and most of them are dated years out.

The rule is proposed, not final. These provisions are not yet effective, and existing requirements remain in place. A proposed rule is still the earliest reliable signal of where enforcement is heading, and this one tells you three things worth knowing now: how fast you will have to report changes to your enrollment information, where Medicare Advantage screening is headed, and what the federal government expects from states and plans it currently cannot require.

I am Dr. Dreama Sloan-Kelly, MD, CCS, CPC, and the useful question for a practice is not what the rule costs the federal budget. It is which of these provisions eventually lands on your billing office.

Executive summary

If you read only this section, here is what matters.

These provisions are not yet effective. Existing requirements remain in place while the comment period runs. The rule published in the Federal Register on November 19, 2026 at 91 FR 74680, and comments are due January 19, 2027.

Four provisions may affect a physician practice directly, each tied to a specific program and each conditional. Applicability is not uniform, so the program a practice participates in determines which of these applies.

Any Medicare-enrolled practice, through enrollment reporting. All Medicare enrollment changes would have to be reported within 30 calendar days. Ownership, practice location, and adverse legal action changes already generally require 30 days; the proposal eliminates the remaining 90-day category and makes the deadline uniform.

Practices billing Medicare Advantage, through enrollment. Eligible providers and suppliers billing MA would have to be enrolled in Original Medicare in an approved status. CMS describes the effective date in its fact sheet as the first day of the plan year beginning two years after a final rule, while the proposed regulatory text hard-codes January 1, 2030. The fact sheet cites § 422.222(a); the operative requirement in the rule text is new § 422.223(a).

Practices with Medicaid fee-for-service volume, through overpayment reporting. The statutory 60-day report-and-return obligation already exists in law; it would gain implementing regulations for Medicaid fee-for-service providers and suppliers, including a six-year lookback.

Physicians who order DMEPOS, through a new revocation ground. CMS proposes a new ground at § 424.535(a)(29) allowing it to revoke a physician or practitioner who ordered an item or service that was not reasonable or necessary, without a prior finding of fraud.

The RADV provisions need careful reading. The February 2023 RADV final rule was vacated and remanded by a federal district court in September 2025, on a notice-and-comment ground only. CRUSH re-proposes those policies through fresh rulemaking; it does not reinstate the vacated rule. The appeal is pending.

Most of the rule governs other parties. Plans, states, DMEPOS suppliers, and Marketplace brokers carry the bulk of the obligations.

What the CRUSH Rule Is, and What It Is Not

CMS issued the Comprehensive Regulations to Uncover Suspicious Healthcare proposed rule, CMS-6098-P, on November 16, 2026, and it published in the Federal Register on November 19, 2026 at 91 FR 74680, running more than 540 pages. It is a standalone discretionary rule, not an annual payment rule, and it would touch Medicare, Medicaid, the Children's Health Insurance Program, and the Health Insurance Marketplace. CMS has said it intends to do program integrity rulemaking of this kind annually going forward, which matters more than any single provision here: this is the first of a series, not a one-time event.

The rule follows a February 27, 2026 Request for Information (91 FR 9803) that drew more than 560 comments. CMS estimates the quantified provisions would produce nearly $90 billion in federal budget savings and roughly $378.51 million in costs between 2027 and 2036.

On the comment deadline: the Federal Register notice sets the comment deadline at January 19, 2027, consistent with 60 calendar days from publication. File any comment on docket CMS-2026-0826 at regulations.gov, referencing file code CMS-6098-P and regulation identifier 0938-AV97.

For the provisions themselves, read the CMS fact sheet for CMS-6098-P alongside the rule text in the Federal Register. CMS also maintains its program integrity resources.

Infographic: CRUSH, what it proposes across provider enrollment, a proposed Original Medicare enrollment requirement for certain Medicare Advantage providers in 2030, RADV audits, DMEPOS suppliers, Medicaid and CHIP, and Marketplace brokers, noting that these proposals are not yet effective and existing requirements still apply

The Provisions That May Reach a Physician Practice Directly

Process graphic: which provisions may affect a physician practice directly, covering uniform 30-day enrollment reporting and Medicaid FFS overpayment regulations, Original Medicare enrollment dated 2030 for Medicare Advantage billing, and provisions reaching plans, states, DMEPOS suppliers, and Marketplace brokers

Most of this rule governs plans, states, and suppliers. Four provisions can reach a practice directly, but each one is tied to a specific program, and which of them applies to you depends on what your practice bills and orders. Read the program condition attached to each rather than assuming all four apply.

Enrollment change reporting becomes a uniform 30 days. This is a correction worth being precise about, because the change is narrower than headlines suggest. Under 42 C.F.R. § 424.516, physician and nonphysician practitioner organizations already have 30 calendar days for change of ownership, any adverse legal action, and a change, addition, or deletion of a practice location. Other providers and suppliers have similar 30-day triggers for ownership and control changes and license actions. The 90-day window covers everything else, such as a legal name change. CMS proposes to delete that remaining 90-day category and require that all providers and suppliers report any change within 30 calendar days, regardless of the type of change or the type of provider, by revising § 424.516 and making matching changes for IDTFs and diabetes prevention programs. Note also that revocation for a missed deadline under § 424.535(a)(9) remains discretionary under the preamble. The practical effect is that changes which currently enjoy the longer window, such as some managing employee or business structure updates, would move onto the shorter clock. Practices that schedule those updates around a quarterly cycle would need to shorten it.

Medicare Advantage billing would require Original Medicare enrollment. Current regulations do not generally require providers and suppliers who bill MA plans to also be enrolled in Original Medicare, and CMS relies on a preclusion list that operates reactively, after a provider has already begun billing. CMS proposes that eligible providers and suppliers billing MA be enrolled in Original Medicare in an approved status, which in practice means not revoked under § 424.535 and not deactivated under § 424.540. That would let CMS apply its full Original Medicare screening, including identity verification, licensure review, site visits, and fingerprint-based background checks.

Two discrepancies are worth flagging, because they are the kind of detail that matters if a practice builds a timeline. First, the CMS fact sheet cites § 422.222(a), but the operative requirement in the rule text is new § 422.223(a), with § 422.222 retaining the existing preclusion list rules through December 31, 2029. Second, the fact sheet describes the effective date as the first day of the plan year beginning two years after publication of the final rule, while the proposed regulatory text hard-codes January 1, 2030 for §§ 422.223 and 422.224. The rule text controls. Also note that the fact sheet names a PACE exception, but that exception did not appear in the portions of the proposed text reviewed here, so treat it as the fact sheet's characterization rather than a text-confirmed carve-out. Track this provision if your group bills MA panels but has providers who are not enrolled in Original Medicare.

Medicaid fee-for-service overpayments gain implementing regulations. The 60-day obligation to report and return overpayments is not new. It is statutory, at 42 U.S.C. § 1320a-7k(d), section 1128J(d) of the Social Security Act, and it has covered Medicaid since 2010. Implementing regulations already exist for Medicare Parts A and B at § 401.305, for Medicare Advantage and Part D at §§ 422.326 and 423.360, and for Medicaid managed care at § 438.608(d)(2). What has been missing is a federal implementing regulation for Medicaid fee-for-service.

CMS proposes to fill that gap through new 42 CFR part 455 subpart J, beginning at § 455.900. The obligated parties are providers of services and suppliers, not states, which matters because the CMS fact sheet wording can be read as placing the duty on states. The deadline mirrors the statute: report and return by the later of 60 days after identification or the due date of any corresponding cost report, with "identified" tracked to the False Claims Act standard of actual knowledge, reckless disregard, or deliberate ignorance. The new elements are a six-year lookback from receipt and application to states six months after publication of a final rule. Do not conflate this with the separate state obligation under § 1903(d)(2) to recover provider overpayments within 60 days of discovery, or with the Medicaid managed care rule at § 438.608(d)(2). For practices with Medicaid fee-for-service volume, the exposure is not a new duty but a new regulatory structure around a duty that already applied.

Medicare Advantage and RADV: What Is Proposed, and What the Litigation Changed

This is the section where accuracy matters most, because the legal history changed what these provisions are.

Mandatory fraud, waste, and abuse reporting. CMS currently encourages but does not require MA organizations and Part D sponsors to report referrals of substantiated or suspicious fraud, waste, and abuse. CMS requires reporting of inappropriate opioid prescribing and of pharmacy payment suspensions, but not payment suspensions for other provider or supplier types. The gap is measurable: for calendar year 2025, CMS found that only 46 percent of Part C and Part D contracts voluntarily reported such referrals, and only 19 percent reported any payment suspensions based on credible allegations of fraud. CMS proposes to make referrals mandatory and to extend payment-suspension reporting to all provider and supplier types, consistent with a July 2018 OIG recommendation.

What this means for a practice: plans will be reporting on you, in a structured way, to the federal government. That raises the value of clean documentation and a clean enrollment record, because a plan's report now has a destination.

RADV reforms, and why the litigation history changes the description. CMS proposes that it would not apply a fee-for-service adjuster, would determine the applicable sampling methodology, and may extrapolate audit findings beginning with payment year 2018 audits. CMS estimates this would let it collect an average of approximately $9 billion per payment year in MA overpayments. Note the proposed regulatory text uses "may," at §§ 422.310(e) and 422.311(a)(2), while the preamble describes extrapolation as intended standard practice.

The backdrop is essential to reading that paragraph correctly. On September 25, 2025, the United States District Court for the Northern District of Texas vacated the February 2023 RADV final rule in Humana v. Becerra. The court's holding was procedural: CMS adopted justifications in the final rule for eliminating the fee-for-service adjuster that were not a logical outgrowth of the reasoning in its 2018 proposed rule, which deprived the public of fair notice and a meaningful opportunity to comment under the Administrative Procedure Act. The court did not hold that RADV extrapolation is unlawful. It vacated the rule and remanded to the agency, and it declined to reach the plaintiffs' alternative arguments about retroactivity and arbitrary and capricious action.

The government appealed. The Fifth Circuit heard oral argument on October 5, 2026, and as of this writing has not issued a decision. The appeal did not automatically stay the district court's order, so the vacatur stands unless the appellate court reverses it.

That is why the description matters. CRUSH re-proposes these RADV policies through fresh notice-and-comment rulemaking. It does not reinstate the vacated 2023 rule, it does not restore the status quo that existed before the vacatur, and it has no legal effect until it is finalized. Any characterization of CRUSH as codifying the 2023 rule is wrong on the current record, and that framing appeared in earlier summaries of this proposal, including an early draft of this article.

Three points about the vacatur itself are commonly overstated, and each one matters to a practice reading the coverage. The court did not decide whether extrapolation is lawful. It did not decide whether abandoning the fee-for-service adjuster was arbitrary and capricious. It did not decide whether applying the policy retroactively to payment year 2018 was permissible. It granted summary judgment on a notice-and-comment defect and remanded, and it stated it need not address the remaining claims. Those arguments remain available against any future final rule.

One citation discrepancy is worth carrying forward rather than resolving informally. The CRUSH preamble cites the appeal as Fifth Circuit No. 25-11082, while the government's brief caption and public docket trackers identify it as No. 25-11293, now captioned Humana v. Kennedy. The docket number should be confirmed on PACER before anyone cites it in a filing or a policy document.

Separate one more distinction. Existing RADV audit authority is not suspended. CMS continues to conduct RADV audits of Medicare Advantage organizations, and audits for plan years before 2018 were not directly affected by the vacated rule. What the litigation and this proposal affect is the methodology CMS may apply, particularly extrapolation and the treatment of the fee-for-service adjuster, for payment year 2018 and later. For a physician practice, this is largely a plan-side fight whose practical consequence is that risk-adjustment documentation scrutiny is not going away, whichever way the appeal lands.

The genuinely new procedural element is the hardship exception: that process currently exists only in sub-regulatory guidance. CMS proposes a regulatory framework identifying the extraordinary circumstances that would qualify a plan sponsor, which should make determinations more consistent and more transparent.

For how documentation holds up once a reviewer asks, see our guide to surviving a payer audit and our breakdown of EM coding in 2026 for how the level of service is built.

DMEPOS: Four Provisions Worth Knowing

DMEPOS suppliers face the most specific changes in the rule, and the fourth has the widest practical reach.

CMS proposes to establish a process to decline surety bonds from noncompliant sureties, modeled on 31 C.F.R. § 223.17(b)(1), because CMS currently lacks authority to reject a bond from a surety that has previously failed to meet its financial obligations. It proposes to expand affiliation reporting beyond the current Form CMS-855S disclosures of owners with five percent or greater interest, partners, managing employees, and officers and directors, to include associated entities such as companies furnishing marketing, fulfillment, wholesale, or device manufacturing services. It proposes to revise the definition of "sufficient evidence" of surety bond liability at 42 C.F.R. § 424.57(a), because sureties frequently claim the evidence is insufficient to avoid paying.

And it proposes to expand the prohibition on unsolicited beneficiary contact. The current rule at 42 C.F.R. § 424.57(c)(11) covers telephone contact without prior permission, subject to limited exceptions, but says nothing about email, text messages, social media, or door-to-door contact. CMS proposes to extend the prohibition to text messages and add new § 424.57(c)(31) covering social media direct messages, email without an opt-out feature, and door-to-door solicitation. The CMS press release describes the same provision, which is worth noting because the release does not use the term DMEPOS or discuss RADV.

If your organization markets DMEPOS to beneficiaries, that last provision is the one to read in full. This section is supplier-facing, and it does not impose new obligations on physician practices that merely order equipment.

One DMEPOS-adjacent provision does reach physicians. CMS proposes a new revocation ground at § 424.535(a)(29) allowing it to revoke a physician or practitioner who ordered a DMEPOS item or service that was not reasonable or necessary, without a prior finding of fraud. The medical necessity of your equipment orders becomes an enrollment question, not only a payment question.

Medicaid and CHIP: Mostly State-Facing, With Two Exceptions

Most of the Medicaid provisions govern states and managed care plans rather than physician practices, and it is worth saying that plainly rather than implying every provision applies to you. States would be permitted to rely on a credible allegation of fraud determination made by CMS or another federal agency, the good cause exception would narrow, state fraud reporting would gain required data elements including NPI, electronic visit verification data would have to be used in prepayment review and preliminary investigations, and NPIs would be required across all eligible provider types. The Medicaid Eligibility Quality Control program would be replaced with federally overseen eligibility audits, and states would face new corrective action plan requirements.

Two provisions do reach providers. The 60-day overpayment rule described earlier applies directly. And providers would face new enrollment disclosure requirements: today providers report all owners and disclose whether any owner or manager has a criminal conviction related to Medicare, Medicaid, or CHIP, and the proposal adds information about owners, managing employees, and adverse legal actions. States would also gain new grounds for denial and termination that mirror existing Medicare grounds, which reduces the room to move from a Medicare revocation into Medicaid billing.

The Marketplace provisions in the rule address agent and broker oversight, including new limitations for certain felony convictions and a codified prohibition on accessing Marketplace systems from outside the United States. Those matter to brokers far more than to physician practices.

What to Do Now

The rule is not final, and no workflow should change because of it this month. Four things are worth doing while the comment period runs.

  1. Read the four provisions that may reach you and identify which apply: the 30-day enrollment reporting requirement applies to every Medicare-enrolled practice; the Original Medicare enrollment requirement applies if you bill MA panels; the overpayment regulation applies if you have Medicaid fee-for-service volume; the revocation ground applies if your physicians order DMEPOS.
  2. Audit your enrollment record for accuracy now. Ownership, managing employees, practice locations, and adverse legal actions are the fields this rule targets, and errors in them are already a problem before any rule is final.
  3. Decide whether to comment. Sixty days from Federal Register publication is a short window, and provisions affecting small practices often draw few practice-level comments.
  4. Do not rebuild workflows yet. The multi-year timeline on the MA enrollment requirement, the absence of a final rule, and the pending RADV appeal mean the disciplined response is preparation, not conversion. A proposed rule can change materially between proposal and final, and this one already carries an active legal challenge in its family of related policies.

If your 2027 planning already includes the payment changes in the CY 2027 Physician Fee Schedule final rule, treat this proposal as the compliance half of the same year. The five readiness decisions we outlined remain the frame, and modifier usage remains the everyday detail that survives every regulatory cycle.

Closing rule: read a proposed rule for the provisions that reach your billing office, not for the size of the savings headline.

If you want a physician-led review of how your documentation, coding, and enrollment practices would hold up under this kind of scrutiny, that is our work. Dr. Sloan-Kelly Consulting helps practices identify undercoding, overcoding, missed reporting opportunities, and documentation gaps.

👉 Schedule a consultation here

Don't miss the next update. Each month I send The DocsDoc Brief — clinical documentation, coding, compliance, and AI insights — straight to your inbox. 👉 Subscribe to The DocsDoc Brief here

Dr. Dreama Sloan-Kelly, MD, CCS, CPC CEO/President, Dr. Sloan-Kelly Consulting LLC

Sources